{"name":"Trutino Biosciences Inc.","slug":"trutino-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQc2N5VjBLTjRfSTdjVmVaUlo2a0tHejdpc0haZzBCNGxEbjVZTUhQNFJKenNzc3p6RWFfODAxN1lYNGplQVJEdTAxWkdEamJRcTh3Y0xOWnhGem1SQ2tlcVVDYjBGQmx5cUZTNFU5ZGVvNVAycWJxOXZRSTdIRktUTA?oc=5","date":"2025-01-22","type":"trial","source":"Oncology Pipeline","summary":"Innate challenges Pfizer in Nectin-4 | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Innate challenges Pfizer in Nectin-4 | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPa0FxTDNzTnV0WlZ0dVozeHptR2NHYzk3bDduMUtUR1l3Y1dwa0tyTllzZmpaOE55SVdjY0JseVlmMzlqX09Kc3R4RnhLeGVtTnA2V0t3QzFmT2tUcDR0TmducmtEVjJZOVc4cWhTOUQ1Y1NuNHFrYTBqUjBTdmVWcVFFM2pXQQ?oc=5","date":"2023-11-22","type":"deal","source":"pharmaphorum","summary":"Boehringer buys cancer immunotherapy firm T3 for $507m - pharmaphorum","headline":"Boehringer buys cancer immunotherapy firm T3 for $507m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQRjU1VUFhbVFsTEU0RnBBVTY5TTUzQlhsekNoQjVYZjRwUmR2bzJ5dGRqNWh0bkRhRDRjZ1daY2JNb1I2RlFyUWVLWGl4MGlsZ2tpQ3R4TXpGU1FmZVFESnBNbXJFdzVzbFpMOFdVbU5ReE9wZ3lwVlhNRXlNM2xjc2syQzhHZnNXYmEwVUtVV3k5QQ?oc=5","date":"2022-06-16","type":"deal","source":"BioPharma Dive","summary":"Boehringer extends cancer dealmaking with right to buy biotech partner - BioPharma Dive","headline":"Boehringer extends cancer dealmaking with right to buy biotech partner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPaWFuQVlvczNhaVZNYjY4RVVaWUxLTE9CTlE4MHc4bWlSdWlDVElDTE5qYjJxelc2NzUzNm51MHFPUnRVX3RGUm45M3VneDFUbzZuQ3UzMUtsVXdSSlpVOVhlbkJkUUF2b1MxYmZjZnIzdFJna0FVQWUxRTNLa2VhODl3NjROYVl5b0pXeE5XUDVtLTlkb2c?oc=5","date":"2022-06-15","type":"pipeline","source":"pharmaphorum","summary":"Boehringer takes option on masked cytokine specialist Trutino - pharmaphorum","headline":"Boehringer takes option on masked cytokine specialist Trutino","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPajE5U243U3VvQ00zbDZoZzlwRk1IbWh2aXh5eFh3WkhBaVZ2SWU4aldMN0s2LUM4cUlhaUdzcEZxRmptRDRfUnVsUHBHdlNadHppdXl2UmUtcWJlRi1OMm1NSTFZN05pazdFVHRHZ0tnUmxXZU5QZm1fdW9JSU1yazdaNG9HMFlaVEktcUJIMGtCb3hqTGRxV3RBcVBGUXZ0Y3ZIYTMtbjdoNGtrNGZrMHVBUC0?oc=5","date":"2022-06-14","type":"deal","source":"Boehringer Ingelheim","summary":"Option to Acquire Trutino Biosciences - Boehringer Ingelheim","headline":"Option to Acquire Trutino Biosciences","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}